These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35657493)
1. Evaluation of the effect of ibuprofen in combination with ciprofloxacin on the virulence-associated traits, and efflux pump genes of Pseudomonas aeruginosa. Khodaparast S; Ghanbari F; Zamani H World J Microbiol Biotechnol; 2022 Jun; 38(7):125. PubMed ID: 35657493 [TBL] [Abstract][Full Text] [Related]
2. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798 [TBL] [Abstract][Full Text] [Related]
3. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333 [TBL] [Abstract][Full Text] [Related]
4. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG). Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial effects of curcumin encapsulated in nanoparticles on clinical isolates of Pseudomonas aeruginosa through downregulation of efflux pumps. Rahbar Takrami S; Ranji N; Sadeghizadeh M Mol Biol Rep; 2019 Apr; 46(2):2395-2404. PubMed ID: 30778922 [TBL] [Abstract][Full Text] [Related]
6. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits. Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589 [TBL] [Abstract][Full Text] [Related]
7. Does ibuprofen affect the expression of alginate genes in pathogenic Pseudomonas aeruginosa strains? Babaei N; Rasti B; Zamani H Folia Microbiol (Praha); 2022 Aug; 67(4):617-623. PubMed ID: 35325409 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India. Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003 [TBL] [Abstract][Full Text] [Related]
10. Comparative transcription analysis of resistant mutants against four different antibiotics in Pseudomonas aeruginosa. Zhang W; Yuan Y; Li S; Deng B; Zhang J; Li Z Microb Pathog; 2021 Nov; 160():105166. PubMed ID: 34480983 [TBL] [Abstract][Full Text] [Related]
11. Role of MexAB-OprM efflux pump in the emergence of multidrug-resistant clinical isolates of Pseudomonas aeruginosa in Mazandaran province of Iran. Ahmadian L; Haghshenas MR; Mirzaei B; Khalili Y; Goli HR Mol Biol Rep; 2023 Mar; 50(3):2603-2609. PubMed ID: 36626068 [TBL] [Abstract][Full Text] [Related]
12. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947 [TBL] [Abstract][Full Text] [Related]
13. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa. Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria. Ugwuanyi FC; Ajayi A; Ojo DA; Adeleye AI; Smith SI Ann Clin Microbiol Antimicrob; 2021 Feb; 20(1):11. PubMed ID: 33531042 [TBL] [Abstract][Full Text] [Related]
15. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model. Adamson DH; Krikstopaityte V; Coote PJ J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps. Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925 [TBL] [Abstract][Full Text] [Related]
17. Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin. Llanes C; Köhler T; Patry I; Dehecq B; van Delden C; Plésiat P Antimicrob Agents Chemother; 2011 Dec; 55(12):5676-84. PubMed ID: 21911574 [TBL] [Abstract][Full Text] [Related]
18. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor. Tohidpour A; Najar Peerayeh S; Mehrabadi JF; Rezaei Yazdi H Curr Microbiol; 2009 Sep; 59(3):352-5. PubMed ID: 19554368 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients. Srivastava P; Sivashanmugam K Infect Genet Evol; 2021 Aug; 92():104824. PubMed ID: 33774177 [TBL] [Abstract][Full Text] [Related]
20. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains. Zahedi Bialvaei A; Rahbar M; Hamidi-Farahani R; Asgari A; Esmailkhani A; Mardani Dashti Y; Soleiman-Meigooni S Microb Pathog; 2021 Apr; 153():104789. PubMed ID: 33556480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]